Letter 2 - Conduct Meeting

The Scientist, July 25, 1994, page 1) says that "many of the attendees [at the 'Convocation on Scientific Conduct'] note with some dismay that active research scientists were largely absent from among the approximately 250 people [in the audience]." Did they really think that many would come? Displaying an interest in misconduct is not a path to advancement in science. Remember what happened to Walter Stewart and Ned Feder. Only sci

Written byCharles Mccutchen
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Displaying an interest in misconduct is not a path to advancement in science. Remember what happened to Walter Stewart and Ned Feder. Only scientists who have already sacrificed their careers would dare to come, and why should they swell the audience for this latest show put on by the biomedical science establishment to give an appearance of action?

If the establishment ever decides to do anything real to halt scientific misconduct, it will use the same subterranean methods it now employs in the service of cover-ups. There will be no fanfare.

Charles W. McCutchen
5213 Acacia Ave.
Bethesda, Md. 20814

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies